Novartis News — every source, one live feed
Track Novartis news in real time — Swiss drugmaker focused on innovative medicines in cardiology, oncology, and immunology.. fllwup^ collects the latest Novartis headlines from every major source into one live feed — free, no account, no algorithm. Coverage aggregated from BBC, Reuters, AP, NYT, TechCrunch, Al Jazeera, and 200+ other outlets.
Latest Novartis headlines
- Novartis joins €97M Kynexis funding round for cognitive disorder drug — FirstWord Pharma
- Why Novartis, Lilly, and Bristol Myers Are Eyeing This Clinical-Stage Cancer Play — 24/7 Wall St.
- Why Novartis, Lilly, and Bristol Myers Are Eyeing This Clinical-Stage Cancer Play — Yahoo Finance
- Novartis defeats UK court bid to invalidate blockbuster drug Entresto patent — Reuters
- A Look at Novartis AG (NVS) After 3.7% Gain -- GF Value $130.44 vs Price $160.31 — GuruFocus
- Novartis data at ESC Congress 2026 reinforce cardiovascular — globenewswire.com
- How Novartis optimized its supply chain — EY
- Novartis AG Stock (NVS) Moved Up by 3.82% on Aug 19: Key Drivers Unveiled — TradingKey
- Bristows and Three New Square defend Novartis’ SPC on Entresto in the UK — JUVE Patent
- Novartis (SWX:NOVN) Stock Looks Reasonable Despite Its 89% Five Year Run — simplywall.st
Follow Novartis live on fllwup^ — or browse all topics.
More Global Stocks & ADRs: browse the category. Compare: fllwup^ vs Flipboard · vs Feedly · vs Google News · vs Apple News.